This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignee: Hangzhou Tianlong Pharmaceutical Co., Ltd.. Active years: 2025-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025-2026
Title: Innovations by Inventor Xin Chai
Introduction
Xin Chai is a prominent inventor based in Hangzhou, China. He has made significant contributions to the field of pharmaceuticals, particularly in vaccine development. With a total of 2 patents, his work is paving the way for advancements in medical science.
Latest Patents
Xin Chai's latest patents include groundbreaking innovations such as the "Respiratory Syncytial Virus mRNA Vaccine, and Preparation Method Therefor and Use Thereof" and the "Herpes Zoster mRNA Vaccine, Preparation Method Therefor, and Use Thereof." These patents reflect his commitment to addressing critical health challenges through innovative solutions.
Career Highlights
Xin Chai is currently employed at Hangzhou Tianlong Pharmaceutical Co., Ltd. His role in this company allows him to focus on research and development, contributing to the advancement of vaccine technology. His expertise and dedication have positioned him as a key player in the pharmaceutical industry.
Collaborations
Xin Chai collaborates with talented individuals such as Gengshen Song and Kai Dong. These partnerships enhance the innovative capacity of his projects and foster a collaborative environment for research and development.
Conclusion
In summary, Xin Chai is an influential inventor whose work in vaccine development is making a significant impact in the medical field. His patents and collaborations highlight his dedication to innovation and improving public health.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile